Cocrystal Pharma's market cap is currently $16.30M. The company's EPS TTM is $-0.2; its P/E ratio is ―; Cocrystal Pharma is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
